Homocysteine and reclassification of cardiovascular disease risk

Journal of the American College of Cardiology

Volumn 58, Issue 10, 2011, Pages 1025-1033

  Veeranna, Vikas ^a   Zalawadiya, Sandip K ^a   Niraj, Ashutosh ^a   Pradhan, Jyotiranjan ^a   Ference, Brian ^a   Burack, Robert C ^a   Jacob, Sony ^a   Afonso, Luis ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

cardiovascular risk; homocysteine; risk reclassification

Indexed keywords

C REACTIVE PROTEIN; HOMOCYSTEINE;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; FRAMINGHAM RISK SCORE; HUMAN; ISCHEMIC HEART DISEASE; MORTALITY; POST HOC ANALYSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; FEMALE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; RISK ASSESSMENT; UNITED STATES;

EID: 80052081252     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.05.028     Document Type: Article

References (40)

1. D. Lloyd-Jones, R. Adams, and M. Carnethon Heart disease and stroke statistics2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 119 2009 e21 e181
2. P.W. Wilson, R.B. D'Agostino, D. Levy, A.M. Belanger, H. Silbershatz, and W.B. Kannel Prediction of coronary heart disease using risk factor categories Circulation 97 1998 1837 1847 (Pubitemid 28213628)
3. J.A. de Lemos, and D.M. Lloyd-Jones Multiple biomarker panels for cardiovascular risk assessment N Engl J Med 358 2008 2172 2174 (Pubitemid 351679606)
4. S.C. Smith Jr. Current and future directions of cardiovascular risk prediction Am J Cardiol 9 2006 28A 32A (Pubitemid 43139717)
5. M. Helfand, D.I. Buckley, and M. Freeman Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force Ann Intern Med 151 2009 496 507
6. P.W. Wilson, M. Pencina, P. Jacques, J. Selhub, R. D'Agostino, and C.J. O'Donnell C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study Circ Cardiovasc Qual Outcomes 1 2008 92 97
7. S. Kaptoge, E. Di Angelantonio, and G. Lowe C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis Lancet 375 2010 132 140
8. P. Greenland, L. LaBree, S.P. Azen, T.M. Doherty, and R.C. Detrano Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals JAMA 291 2004 210 215 (Pubitemid 38082815)
9. H. Refsum, A.D. Smith, and P.M. Ueland Facts and recommendations about total homocysteine determinations: an expert opinion Clin Chem 50 2004 3 32 (Pubitemid 38125696)
10. D.J. Brotman, E. Walker, M.S. Lauer, and R.G. O'Brien In search of fewer independent risk factors Arch Intern Med 165 2005 138 145
11. L.L. Humphrey, R. Fu, K. Rogers, M. Freeman, and M. Helfand Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis Mayo Clin Proc 83 2008 1203 1212
12. R.L. Sacco, K. Anand, and H.S. Lee Homocysteine and the risk of ischemic stroke in a triethnic cohort: the Northern Manhattan Study Stroke 35 2004 2263 2269 (Pubitemid 39311247)
13. Y. Sun, K.L. Chien, H.C. Hsu, T.C. Su, M.F. Chen, and Y.T. Lee Use of serum homocysteine to predict stroke, coronary heart disease and death in ethnic Chinese 12-year prospective cohort study Circ J 73 2009 1423 1430
14. D. Tanne, M. Haim, and U. Goldbourt Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease Stroke 34 2003 632 636 (Pubitemid 36307383)
15. D.E. Bild, D.A. Bluemke, and G.L. Burke Multi-ethnic study of atherosclerosis: objectives and design Am J Epidemiol 156 2002 871 881 (Pubitemid 35215769)
16. MESA Coordinating Center Multi-Ethnic Study of Atherosclerosis Field Center Manual of Operations 2001 University of Washington Seattle, WA
17. Centers for Disease Control and Prevention (CDC): National Health and Nutrition Examination Survey NCHS research ethics review board (ERB) approval http://www.cdc.gov/nchs/nhanes/irba98.htm Accessed September 15, 2010
18. A. Araki, and Y. Sako Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection J Chromatogr 422 1987 43 52 (Pubitemid 17167357)
19. Centers for Disease Control and Prevention (CDC): National Health and Nutrition Examination Survey NHANES III http://www.cdc.gov/nchs/nhanes/nh3data. htm Accessed July 5, 2011
20. S. Lonati, C. Novembrino, and S. Ippolito Analytical performance and method comparison study of the total homocysteine fluorescence polarization immunoassay (FPIA) on the AxSYM analyzer Clin Chem Lab Med 42 2004 228 234 (Pubitemid 38401454)
21. Centers for Disease Control and Prevention (CDC): Data Access NHANES III linked mortality file http://www.cdc.gov/nchs/data-access/data-linkage/ mortality/nhanes3-linkage.htm Accessed July 5, 2011
22. National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 2002 314321
23. M.J. Pencina, R.B. D'Agostino Sr., R.B. D'Agostino Jr., and R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172 discussion 20712 (Pubitemid 351193639)
24. M.J. Pencina, R.B. D'Agostino Sr., and E.W. Steyerberg Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers Stat Med 30 2011 11 21
25. J. Yeboah, A.R. Folsom, and G.L. Burke Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the Multi-Ethnic Study of Atherosclerosis Circulation 120 2009 502 509
26. P.M. Ridker, J.E. Manson, J.E. Buring, J. Shih, M. Matias, and C.H. Hennekens Homocysteine and risk of cardiovascular disease among postmenopausal women JAMA 281 1999 1817 1821 (Pubitemid 29231132)
27. Homocysteine Studies Collaboration Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis JAMA 288 2002 2015 2022
28. I.J. Kullo, G. Li, and L.F. Bielak Association of plasma homocysteine with coronary artery calcification in different categories of coronary heart disease risk Mayo Clin Proc 81 2006 177 182 (Pubitemid 43205770)
29. W. de Ruijter, R.G. Westendorp, and W.J. Assendelft Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study BMJ 338 2009 a3083
30. M. Helfand, D. Buckley, and C. Fleming Screening for Intermediate Risk Factors for Coronary Heart Disease: Systematic Evidence Synthesis Evidence Synthesis No. 73. AHRQ Publication No. 10-05141-EF-1 2009 Agency for Healthcare Research and Quality Rockville, MD
31. T.S. Polonsky, R.L. McClelland, and N.W. Jorgensen Coronary artery calcium score and risk classification for coronary heart disease prediction JAMA 303 2010 1610 1616
32. Y.M. Smulders, and H.J. Blom The homocysteine controversy J Inherit Metab Dis 34 2011 93 99
33. A.J. Marti-Carvajal, I. Sola, D. Lathyris, and G. Salanti Homocysteine lowering interventions for preventing cardiovascular events Cochrane Database Syst Rev 4 2009 CD006612
34. E.R. Miller 3rd, S. Juraschek, R. Pastor-Barriuso, L.A. Bazzano, L.J. Appel, and E. Guallar Meta-analysis of folic acid supplementation trials on risk of cardiovascular disease and risk interaction with baseline homocysteine levels Am J Cardiol 106 2010 517 527
35. J.M. Armitage, L. Bowman, and R.J. Clarke Effects of homocysteine- lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial JAMA 303 2010 2486 2494
36. K.H. Bonaa, I. Njolstad, and P.M. Ueland Homocysteine lowering and cardiovascular events after acute myocardial infarction N Engl J Med 354 2006 1578 1588
37. E. Lonn, S. Yusuf, and M.J. Arnold Homocysteine lowering with folic acid and B vitamins in vascular disease N Engl J Med 354 2006 1567 1577
38. C.H. Hennekens, and R.B. D'Agostino Global risk assessment for cardiovascular disease and astute clinical judgement Eur Heart J 24 2003 1899 1900 (Pubitemid 37322697)
39. J. Liu, Y. Hong, and R.B. D'Agostino Sr. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study JAMA 291 2004 2591 2599 (Pubitemid 38702777)
40. M.A. Hlatky, P. Greenland, and D.K. Arnett Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association Circulation 119 2009 2408 2416